Welcome to Integro

Our approach is simple. We have a single point of focus. The patient. Every decision we make is dictated entirely by the needs of the specific individual.

We have no vested interest in recommending preferred treatments. When making an assessment, we explore all suitable options and examine each case with the complete Integro Clinic team before recommending a solution.   

Integro Clinic’s doctors are all conventional medical specialists who also embrace what cannabis medicine prescribing can offer when conventional medicine can’t help. Our clinicians are backed by a management team with years of experience. We also have close working relationships with a specialist pharmacy and other partner organisations, allowing us to deliver a positive patient experience from the initial contact right through to prescription and the delivery of required medicines to the patient’s door. We also offer a follow up service once you have started taking your medicines to make sure you have all the information and support you need.

Learn more about the team of experts that make the up the Integro team here.

Cannabis Based Medicine (cannabinoid) prescribing is very new to the UK. With cannabis medicine, in common with conventional medicines, different people respond differently to each medication. Once we get to know you and your medical condition, and if we think cannabinoids can help you, we will recommend the best products for you, provide you with a prescription and, if you wish, arrange for a pharmacy to supply them to you.

In some cases our doctors may recommend more conventional treatments before prescribing a cannabis medicine.

Learn more about cannabis medicine treatments here.

In February 2019, Grow Pharma completed the first bulk import of cannabis into the UK and supplied one of the very first prescriptions for cannabis medicine in the UK. By November 2019, less than one year later, Grow Pharma was responsible for approximately 80% of the cannabis medicine prescriptions dispensed across the entire country. With this partnership, Integro is able to offer every patient issued with a cannabis medicine prescription delivery of their medicines to anywhere in the UK.

Grow Pharma is also a leading voice in the education of the UK medical profession about the benefits of cannabis medicine. Thanks to the information made available to us through this partnership, Integro Clinics are up to date about the latest medical findings and offer clear direction and treatment guidance related to cannabis.

Grow Pharma is a joint venture from Grow Group and IPS Pharma. IPS Pharma is an independent international pharmaceutical services company with a focus on three main areas: unlicensed medicines, clinical trials and ‘specials’ sourcing and manufacturing. From their state-of-the-art facility in Surrey, IPS has the capacity to deliver over 20,000 different formulates for unlicensed medicines, Investigational Medical Products (IMP) and comparators for clinical trials. IPS is a respected member of the Association of Pharmaceuticals Unlicensed Medicines Manufacturers (APSM). They are also audited and licensed by the Medicines and Healthcare products Regulatory Agency (MHRA).

Learn more about the partners that make our work possible here.

Working with our partner organisations, we ensure that our standards comply with national, Government, and healthcare guidelines to maintain your safety and good clinical practice. We follow the regulations and guidelines of organisations like the Department of Health and Social Care, MHRA and the Home Office to ensure legal and medical compliance.

Adverse effects of medication prescribed through Integro clinic should be reported immediately to the Integro clinic Nurse on 020 7123 4567 or emailed to info@integroclinics.com.

Adverse events should also be reported to the MHRA via the process as outlaid on the following link.

Patients should also contact the dispensing pharmacy for which the prescription medication was obtained from